A broader national rollout is expected next year, starting with 400,000 doses that would be received through a deal between lenacapavir’s manufacturer Gilead Sciences and the Global Fund to Fight AIDS
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...





